Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Identification of small molecules for human hepatocyte expansion and iPS differentiation

Identification of small molecules for human hepatocyte expansion and iPS differentiation

Thumbnail Image
Download
Name

Bhatia_Identification of.pdf

Size

4.3 MB

Format

Adobe PDF

Checksum (MD5)

530ac8632ebe8d81771a867b2e76ee25

Author(s)
Shan, Jing
•
Ross, Nathan T.
•
Logan, David J.
•
Thomas, David
•
Duncan, Stephen A.
•
North, Trista E.
•
Goessling, Wolfram
•
Carpenter, Anne E.
•
Schwartz, Robert E.
•
Bhatia, Sangeeta N
Date Issued
June 2013
Journal
Nature Chemical Biology
Citation
Shan, Jing, Robert E Schwartz, Nathan T Ross, David J Logan, David Thomas, Stephen A Duncan, Trista E North, Wolfram Goessling, Anne E Carpenter, and Sangeeta N Bhatia. “Identification of Small Molecules for Human Hepatocyte Expansion and iPS Differentiation.” Nat Chem Biol 9, no. 8 (June 2, 2013): 514–520.
Version
Author's final manuscript
Abstract
Cell-based therapies hold the potential to alleviate the growing burden of liver diseases. Such therapies require human hepatocytes, which, within the stromal context of the liver, are capable of many rounds of replication. However, this ability is lost ex vivo, and human hepatocyte sourcing has limited many fields of research for decades. Here we developed a high-throughput screening platform for primary human hepatocytes to identify small molecules in two different classes that can be used to generate renewable sources of functional human hepatocytes. The first class induced functional proliferation of primary human hepatocytes in vitro. The second class enhanced hepatocyte functions and promoted the differentiation of induced pluripotent stem cell–derived hepatocytes toward a more mature phenotype than what was previously obtainable. The identification of these small molecules can help address a major challenge affecting many facets of liver research and may lead to the development of new therapeutics for liver diseases.
MIT Department
Whitaker College of Health Sciences and Technology
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/86114
DOI of Published Version
https://doi.org/10.1038/nchembio.1270
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.